Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Editor-in-Chief

Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 11 Issue: 3, March

Editorial [Hot Topic: Prospective Clinical Role for Anticancer Garlic Organosulfur Compounds (Guest Editor: Hassan T. Hassan)]

Volume:11   Issue: 3
Pp: 247-248
Hassan T. Hassan
DOI: 10.2174/187152011795347478
Published on: 01 March, 2012

Anticancer Effects of Garlic and Garlic-derived Compounds for Breast Cancer Control

Volume:11   Issue: 3
Pp: 249-253
Airo Tsubura, Yen-Chang Lai, Maki Kuwata, Norihisa Uehara and Katsuhiko Yoshizawa
DOI: 10.2174/187152011795347441
Published on: 01 March, 2012

Modulation of Histone Acetylation by Garlic Sulfur Compounds

Volume:11   Issue: 3
Pp: 254-259
Nathalie Druesne-Pecollo and Paule Latino-Martel
DOI: 10.2174/187152011795347540
Published on: 01 March, 2012

Anti-Proliferative Activity of Synthetic Ajoene Analogues on Cancer Cell-Lines

Volume:11   Issue: 3
Pp: 260-266
Catherine H. Kaschula, Roger Hunter, Hassan T. Hassan, Nashia Stellenboom, Jonathan Cotton, Xiao Q. Zhai and M. Iqbal Parker
DOI: 10.2174/187152011795347450
Published on: 01 March, 2012

Chemical Properties and Mechanisms Determining the Anti-Cancer Action of Garlic-Derived Organic Sulfur Compounds

Volume:11   Issue: 3
Pp: 267-271
Claudia Cerella, Mario Dicato, Claus Jacob and Marc Diederich
DOI: 10.2174/187152011795347522
Published on: 01 March, 2012

Harnessing Impaired Energy Metabolism in Cancer Cell: Small Molecule- Mediated Ways to Regulate Tumorigenesis

Volume:11   Issue: 3
Pp: 272-279
Govardhan K. Shroff, Ramyasri Kuna, Kethora Dirsipam, Ravishekar Yalagala and Prasenjit Mitra
DOI: 10.2174/187152011795347531
Published on: 01 March, 2012

Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines

Volume:11   Issue: 3
Pp: 280-284
Govind J. Kapadia, Magnus A. Azuine, G. Subba Rao, Takanari Arai, Akira Iida and Harukuni Tokuda
DOI: 10.2174/187152011795347504
Published on: 01 March, 2012

BRAF as a Target for Cancer Therapy

Volume:11   Issue: 3
Pp: 285-295
Rodrigo Dienstmann and Josep Tabernero
DOI: 10.2174/187152011795347469
Published on: 01 March, 2012

Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions

Volume:11   Issue: 3
Pp: 296-306
Jawaher Ansari, Syed A Hussain, Abdulla Alhasso, Rana Mahmood, Asif Ansari and John Glaholm
DOI: 10.2174/187152011795347496
Published on: 01 March, 2012

Astemizole: an Old Anti-histamine as a New Promising Anti-cancer Drug

Volume:11   Issue: 3
Pp: 307-314
Janice Garcia-Quiroz and Javier Camacho
DOI: 10.2174/187152011795347513
Published on: 01 March, 2012

Lenalidomide – Current Understanding of Mechanistic Properties

Volume:11   Issue: 3
Pp: 315-326
Nishant Tageja
DOI: 10.2174/187152011795347487
Published on: 01 March, 2012